For almost three-quarters of overweight sufferers with fibromyalgia, drastic caloric restriction in a small trial led to 30% or larger discount in symptom severity in solely 3 weeks, researchers reported.

The findings assist an rising speculation that caloric restriction has its personal analgesic impact unbiased of weight reduction, in accordance with Aaron Stubbs, MD, of Michigan Medication in Ann Arbor, and colleagues writing in ACR Open Rheumatology.

“Though a bigger examine with a management group could be the subsequent step in investigating this affiliation, this gives necessary info for clinicians who counsel sufferers on alternate options to pharmacologic remedies for ache and different somatic signs,” the researchers concluded.

A connection between weight problems and power ache has been effectively documented, with U.S. nationwide knowledge indicating a 60% improve in prevalence of persistent ache in people with weight problems in contrast with the non-obese. That has led to numerous research searching for to find out whether or not weight reduction would relieve ache in such people.

Amongst these was a Michigan Medication examine revealed in 2017 with most of the identical authors that examined a really low-calorie weight loss plan for overweight folks with ache (not particularly fibromyalgia), discovering important enchancment after 12 weeks. Though ache reduction was tied to weight reduction in that evaluation, the reduction “was not confined to weight-bearing joints,” Stubbs and colleagues famous. That remark recommended that “the advantages seemingly conferred by weight reduction can’t be attributed to a discount in mechanical stress on weight-bearing joints alone; quite, it appears possible that no less than a subset of sufferers expertise a world discount in ache sensitivity.”

And if that is the case, then maybe a low-calorie weight loss plan would present profit lengthy earlier than sufferers start to lose important weight — therefore the present examine.

Stubbs and co-authors drew on a weight administration program working on the College of Michigan for folks with weight problems, figuring out 195 contributors who scored no less than 4 on Fibromyalgia Survey Standards (FSC) at baseline. This rating represents no less than reasonable levels of ache and pain-related issues. These people agreed to a liquid meal substitute weight loss plan supplying not more than 800 kcal/day, which was alleged to final 12 weeks. The first evaluation was carried out after 3 weeks, with secondary outcomes assessed in 119 who stayed the 12-week course.

Imply physique mass index at baseline was 41.5 (SD 5.2); sufferers’ imply age was 45, and 74% had been girls. About half additionally had depressive signs.

At week 3, contributors had misplaced a mean of about 5.6% of physique weight, with imply FSC scores falling from 8.39 at baseline to 4.78 throughout all contributors. Symptom reductions of no less than 30% had been seen in 72%. There was an ever-so-slight pattern towards larger weight reduction in sufferers with very marked enchancment (6.0%) and people with reasonable enchancment (5.5%) in contrast with these exhibiting little to no enchancment (5.2%), which the investigators dismissed as trivial.

Certainly, whereas weight reduction continued over the complete 12 weeks, reaching a imply 15% of physique weight, additional ache reduction was not noticed amongst these exhibiting no less than reasonable enchancment at week 3. (Common FSC scores did proceed to say no by way of week 8 in these with little to no preliminary enchancment, dipping under 5.0, and all teams confirmed a rebound in imply scores after week 8.)

Stubbs and colleagues speculated on potential mechanisms to clarify the fast onset of ache reduction. One candidate is that caloric restriction inhibits numerous inflammatory mediators. Earlier research have discovered results on interleukin-10, C-reactive protein, lipopolysaccharide binding protein, and inhibitory issue κB-α, though not persistently. Alternatively, Stubbs’ group recommended, caloric restriction may relieve ache “by way of central alteration of neurotransmission” through motion on, for instance, neuropeptide Y or opioid receptors.

The examine did include one main limitation, the researchers stated: the shortage of a management group. “Clearly, randomized managed scientific trials will probably be mandatory to verify these outcomes,” the group wrote. Stubbs and colleagues additionally acknowledged that no validated thresholds have been established for FSC rating modifications that could possibly be thought-about clinically important.

  • author['full_name']

    John Gever was Managing Editor from 2014 to 2021; he’s now a daily contributor.


The examine authors declared they’d no related monetary pursuits.